Vatalanib Dihydrochloride

Vatalanib Dihydrochloride
  • CAS No.:212141-51-0
Other grades of this product :
Vatalanib Dihydrochloride Basic information
Product Name:Vatalanib Dihydrochloride
Synonyms:CGP-79787 Dihydrochlorid;N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine Dihydrochloride;Vatalanib Dihydrochloride;CGP-79787 Dihydrochloride;Vatalanib 2hcl((ZK-222584,PTK 787);Vatalanib dihydrochloride (PTK787);CGP-79787;CGP-79787D
CAS:212141-51-0
MF:C20H17Cl3N4
MW:419.74
EINECS:
Product Categories:Heterocycles;Tyrosine Kinase Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Antineoplastic;Inhibitors
Mol File:212141-51-0.mol
Vatalanib Dihydrochloride Chemical Properties
Melting point 268-2700C
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 20 mg/ml with warming) or in Water (up to 100 mg/ml)
form solid
color White or off-white
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20°C for up to 3 months.
CAS DataBase Reference212141-51-0
Safety Information
Risk Statements 36/37/38
Safety Statements 24/25
HS Code 29333990
MSDS Information
Vatalanib Dihydrochloride Usage And Synthesis
DescriptionVatalanib is an antagonist of the VEGF receptors, inhibiting the receptor tyrosine kinase activities of VEGFR1 (Flt1), VEGFR2 (KDR), and VEGFR3 (Flt4) with IC50 values of 77, 37, and 190 nM, respectively. It less potently inhibits PDGF and c-Kit (IC50 = 600 and 700 nM) and has no effect on a large panel of additional kinases. Vatalanib completely blocks retinal neovascularization in oxygen-induced ischemic retinopathy in mice, suggesting its use in diabetic retinopathy and other diseases featuring aberrant vascular development.
Chemical PropertiesWhite to Off-White Crystalline Powder
UsesVascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Antineoplastic.
UsesVatalanib (PTK787) is an inhibitor of VEGFR2/KDR, Flt-1 and c-Kit with IC50 of 37 nM, 77 nM and 730 nM, respectively.
References1) Wood?et al. (2000),?PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration;? Cancer Res.,?60?2178 2) Lin?et al. (2002),?The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in bone marrow microenvironment;? Cancer Res.,?62?5019
Vatalanib Dihydrochloride Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye